Terry's nails, a nail abnormality characterized by a white, frosted appearance with a reddish-brown band at the tip, can ...

Our nails often reflect more than just cosmetic health—they can serve as windows into hidden medical conditions. One such subtle yet significant sign is known as Terry’s nails, a condition that may ...

Terry's nails, characterized by a white, frosted appearance with a narrow pink band, can indicate underlying health issues like liver cirrhosis, heart ...

The FDA has approved semaglutide for treating MASH, a significant advancement in liver disease management. Semaglutide, ...

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

In patients with hepatocellular carcinoma (HCC), hyponatremia is an independent predictor of increased rates of in-hospital mortality, with a greater impact reported among those with cirrhosis, ...

Liver failure syndromes are characterized by a dysregulated immune response leading to immune paralysis. Adrenomedullin (ADM) ...

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

The FDA has granted accelerated approval to semaglutide (Wegovy; Novo Nordisk) injection 2.4 mg for the treatment of adults with metabolic dysfunction–associated steatohepatitis (MASH) with moderate ...

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...